{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:28:04Z","timestamp":1777674484085,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Retinoblastoma is the most common intraocular malignant tumor in childhood. Although current treatments offer a high survival rate, treatment toxicity, tumor relapse, and treatment resistance require a deeper understanding of the disease mechanisms to develop adapted therapies. Microscopically, this tumor is characterized by different states of differentiation and proliferation, ranging from poorly differentiated to well-differentiated retinoblastoma. Retinocytoma, on the other hand, is a benign non-proliferative tumor. Recent next-generation multi-omics analyses classified retinoblastoma tumors in subtypes 1 or 2, subtype 2 presenting a later age of onset, more genetic alterations, and higher metastatic potential. In parallel, several single-cell transcriptomics studies demonstrated intratumoral heterogeneity. However, mapping the different cell populations directly on the tumor and comparing histological features and molecular subtypes remains an unmet need.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Spatial transcriptomics was used to characterize a primary enucleated case with two histologically distinct areas. The whole transcriptomic profile of sixteen regions of interest, covering the two differentiation patterns of the tumor and the non-tumoral retina, was analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The clustering of the regions of interest based on whole transcriptome data correlated with the histological description: cluster 1 (6 regions of interest) corresponded to highly differentiated areas and cluster 2 (6 regions of interest) to poorly differentiated areas. They showed enrichment for phototransduction and proliferation respectively, confirmed by immunohistochemistry for markers of these pathways. The publicly available molecular signatures of the two retinoblastoma subtypes categorized our regions of interest into two groups, which correlated perfectly with histological observation and transcriptomic profiles. Further analysis of the expression of specific senescence markers in the well-differentiated area did not support the diagnosis of retinocytoma as it did not confirm the expected up-regulation seen in this tumor type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study demonstrates a strong correlation between histological observation and molecular profiling, representing the first mapping of retinoblastoma composed of adjacent molecular subtypes 1 and 2. It also highlights the diagnostic ambiguity between retinocytoma and well-differentiated non-proliferative subtype 1 retinoblastoma and emphasizes the need for specific biomarkers to differentiate these two tumor types.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-14814-5","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T07:41:14Z","timestamp":1756798874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatial transcriptomics of retinoblastoma: a visual window\u00a0on intra-patient heterogeneity"],"prefix":"10.1186","volume":"25","author":[{"given":"A. P.","family":"Moulin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Thevenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mazzeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tissot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. L.","family":"Munier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"4","key":"14814_CR1","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson","year":"1971","unstructured":"Knudson AG. Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971;68(4):820\u20133.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"14814_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/bjophthalmol-2016-309298","volume":"101","author":"FL Munier","year":"2017","unstructured":"Munier FL, Mosimann P, Puccinelli F, Gaillard MC, Stathopoulos C, Houghton S, et al. First-line intra-arterial versus intravenous chemotherapy in unilateral sporadic group D retinoblastoma: evidence of better visual outcomes, ocular survival and shorter time to success with intra-arterial delivery from retrospective review of 20 years of treatment. Br J Ophthalmol. 2017;101(8):1086\u201393.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"14814_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","volume":"96","author":"FL Munier","year":"2012","unstructured":"Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, et al. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96(8):1078\u201383.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"14814_CR4","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ophtha.2017.11.010","volume":"125","author":"FL Munier","year":"2018","unstructured":"Munier FL, Moulin A, Gaillard MC, Bongiovanni M, Decembrini S, Houghton S, et al. Intracameral chemotherapy for globe salvage in retinoblastoma with secondary anterior chamber invasion. Ophthalmology. 2018;125(4):615\u20137.","journal-title":"Ophthalmology"},{"key":"14814_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2019.05.005","author":"FL Munier","year":"2019","unstructured":"Munier FL, Beck-Popovic M, Chantada GL, Cobrinik D, Kivela TT, Lohmann D, et al. Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. Alive, with good vision and no comorbidity. Prog Retin Eye Res. 2019. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.05.005.","journal-title":"Prog Retin Eye Res"},{"issue":"40","key":"14814_CR6","doi-asserted-by":"publisher","first-page":"E9391","DOI":"10.1073\/pnas.1808903115","volume":"115","author":"HP Singh","year":"2018","unstructured":"Singh HP, Wang S, Stachelek K, Lee S, Reid MW, Thornton ME, et al. Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors. Proc Natl Acad Sci U S A. 2018;115(40):E9391-400.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"14814_CR7","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/hmg\/ddn024","volume":"17","author":"H Dimaras","year":"2008","unstructured":"Dimaras H, Khetan V, Halliday W, Orlic M, Prigoda NL, Piovesan B, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 2008;17(10):1363\u201372.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"14814_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04390-4","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Li Y, Han Y, Feng Y, Zhou M, Zong C, et al. Single-cell transcriptome profiling reveals intratumoural heterogeneity and malignant progression in retinoblastoma. Cell Death Dis. 2021;12(12): 1100.","journal-title":"Cell Death Dis"},{"issue":"5","key":"14814_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04904-8","volume":"13","author":"C Wu","year":"2022","unstructured":"Wu C, Yang J, Xiao W, Jiang Z, Chen S, Guo D, et al. Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma. Cell Death Dis. 2022;13(5): 438.","journal-title":"Cell Death Dis"},{"issue":"6","key":"14814_CR10","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.6.18","volume":"62","author":"J Collin","year":"2021","unstructured":"Collin J, Queen R, Zerti D, Steel DH, Bowen C, Parulekar M, et al. Dissecting the transcriptional and chromatin accessibility heterogeneity of proliferating cone precursors in human retinoblastoma tumors by single cell sequencing-opening pathways to new therapeutic strategies. Invest Ophthalmol Vis Sci. 2021;62(6): 18.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"14814_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25792-0","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Ottaviani D, Sefta M, Desbrousses C, Chapeaublanc E, Aschero R, et al. A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal\/ganglion cell gene expression. Nat Commun. 2021;12(1): 5578.","journal-title":"Nat Commun"},{"key":"14814_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4: 2612.","journal-title":"Nat Commun"},{"key":"14814_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle J, Gfeller D. EPIC: A tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol. 2020;2120:233\u201348.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"14814_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30717","volume":"71","author":"R Aschero","year":"2024","unstructured":"Aschero R, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, et al. Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma. Pediatr Blood Cancer. 2024;71(1): e30717.","journal-title":"Pediatr Blood Cancer"},{"key":"14814_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI158450","author":"L Zhang","year":"2022","unstructured":"Zhang L, Pitcher LE, Yousefzadeh MJ, Niedernhofer LJ, Robbins PD, Zhu Y. Cellular senescence: a key therapeutic target in aging and diseases. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI158450.","journal-title":"J Clin Invest"},{"issue":"1","key":"14814_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/ceo.12132","volume":"42","author":"BL Theriault","year":"2014","unstructured":"Theriault BL, Dimaras H, Gallie BL, Corson TW. The genomic landscape of retinoblastoma: a review. Clin Exp Ophthalmol. 2014;42(1):33\u201352.","journal-title":"Clin Exp Ophthalmol"},{"issue":"52","key":"14814_CR17","doi-asserted-by":"publisher","first-page":"33628","DOI":"10.1073\/pnas.2011780117","volume":"117","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang Y, Zhang YY, Li YP, Hua ZQ, Zhang CJ, et al. Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin. Proc Natl Acad Sci U S A. 2020;117(52):33628\u201338.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"14814_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mc.20179","volume":"45","author":"H Dimaras","year":"2006","unstructured":"Dimaras H, Coburn B, Pajovic S, Gallie BL. Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog. 2006;45(5):333\u201343.","journal-title":"Mol Carcinog"},{"key":"14814_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep25264","volume":"6","author":"IE Kooi","year":"2016","unstructured":"Kooi IE, Mol BM, Massink MP, Ameziane N, Meijers-Heijboer H, Dommering CJ, et al. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci Rep. 2016;6: 25264.","journal-title":"Sci Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14814-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14814-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:16:16Z","timestamp":1757477776000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14814-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14814"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14814-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki and was approved by the local ethic committee (Commission cantonale d\u2019\u00e9thique de la recherche sur l\u2019\u00eatre humain (CER-VD), protocol 340_15). Written informed consent was obtained from the child\u2019s parents.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1410"}}